Revolutionizing Addiction Treatment: A Comparative Analysis of ReNAD Biologics’ NAD+ Therapy and Traditional Buprenorphine Protocols
Short Communication | Open Access
| Volume 11 | Issue 1
Article DOI : https://doi.org/10.47739/2333-665X.1046
- 1. ReNAD Biologics Corp, USA
- 2. Hospice Medical Director, USA
Luke Dandrea, ReNAD Biologics Corp, USA, Email: Luke@renadrecovery.com